TOLvaptan Effects on RenAl FuNCtion in Heart FailurE

Trial Profile

TOLvaptan Effects on RenAl FuNCtion in Heart FailurE

Phase of Trial: Phase IV

Latest Information Update: 17 May 2016

At a glance

  • Drugs Tolvaptan (Primary) ; Furosemide
  • Indications Heart failure
  • Focus Pharmacodynamics
  • Acronyms TOLERANCE
  • Most Recent Events

    • 14 Nov 2013 Planned end date changed from 1 Mar 2013 to 31 Dec 2013 as reported by University Hospital Medical Information Network - Japan.
    • 17 May 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top